Solomon Islands

Solomon Islands

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
10.91 (9 - 13.18) 2015 Modelled WHO
18.83 (17.57 - 20.15) 2013 Modelled Schweitzer et al, 2015
6.33 (4.87 - 7.42) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.89 (5.26 - 8) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (5.20 - 8.21) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7.13 (5.19 - 8.41) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7.28 (5.08 - 8.72) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7.43 (5.20 - 8.90) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7.67 (5.42 - 9.13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7.93 (5.67 - 9.37) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8.18 (5.89 - 9.69) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8.35 (6.03 - 9.95) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8.54 (6.17 - 10.13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8.83 (6.34 - 10.45) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9.15 (6.50 - 10.85) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9.42 (6.64 - 11.24) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9.57 (6.68 - 11.49) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9.65 (6.70 - 11.57) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9.76 (6.74 - 11.70) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9.88 (6.76 - 11.91) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9.99 (6.79 - 12.15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10.09 (6.81 - 12.39) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.27 (6.97 - 12.57) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10.59 (7.23 - 12.94) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10.97 (7.50 - 13.41) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11.32 (7.70 - 13.84) 1996 Modelled IHME, GBD 2019 (accessed 2022)
11.54 (7.78 - 14.16) 1995 Modelled IHME, GBD 2019 (accessed 2022)
11.72 (7.83 - 14.41) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11.96 (7.90 - 14.74) 1993 Modelled IHME, GBD 2019 (accessed 2022)
12.25 (7.94 - 15.20) 1992 Modelled IHME, GBD 2019 (accessed 2022)
12.58 (8 - 15.73) 1991 Modelled IHME, GBD 2019 (accessed 2022)
12.93 (8.01 - 16.30) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.74 (5.21 - 7.86) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
3.1 (2 - 4.90) 2016 Survey/reported WHO WPRO, Woodring J et al, 2017
2.93 (2.02 - 3.98) 2015 Modelled WHO
1.29 (0.67 - 1.78) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.48 (0.77 - 2.05) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.55 (0.80 - 2.08) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.6 (0.79 - 2.19) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (0.74 - 2.31) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.73 (0.68 - 2.46) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (0.71 - 2.57) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.88 (0.77 - 2.70) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.98 (0.84 - 2.83) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (0.92 - 2.96) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (0.99 - 3.08) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.04 - 3.26) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (1.11 - 3.44) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (1.18 - 3.65) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (1.24 - 3.76) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (1.29 - 3.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (1.30 - 3.88) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.83 (1.32 - 3.94) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.84 (1.32 - 3.95) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (1.33 - 3.97) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (1.33 - 3.97) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (1.32 - 3.98) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (1.33 - 3.99) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (1.36 - 3.99) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.87 (1.36 - 4.03) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.89 (1.37 - 4.10) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (1.42 - 4.32) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.31 (1.56 - 4.73) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.74 (1.74 - 5.33) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.26 (1.95 - 6.14) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.82 (2.18 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.71 - 1.05) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
41,508 (31,934 - 48,640) 2019 Modelled IHME, GBD 2019 (accessed 2020)
42,578 (32,948 - 49,703) 2019 Modelled IHME, GBD 2019 (accessed 2022)
42,791 (32,633 - 49,735) 2018 Modelled IHME, GBD 2019 (accessed 2022)
42,719 (31,609 - 50,211) 2017 Modelled IHME, GBD 2019 (accessed 2022)
42,773 (31,173 - 50,396) 2016 Modelled IHME, GBD 2019 (accessed 2022)
42,880 (29,874 - 51,403) 2015 Modelled IHME, GBD 2019 (accessed 2022)
43,008 (29,981 - 51,476) 2014 Modelled IHME, GBD 2019 (accessed 2022)
43,579 (30,743 - 51,887) 2013 Modelled IHME, GBD 2019 (accessed 2022)
44,272 (31,634 - 52,372) 2012 Modelled IHME, GBD 2019 (accessed 2022)
44,793 (32,260 - 52,986) 2011 Modelled IHME, GBD 2019 (accessed 2022)
44,867 (32,356 - 53,395) 2010 Modelled IHME, GBD 2019 (accessed 2022)
45,007 (32,553 - 53,390) 2009 Modelled IHME, GBD 2019 (accessed 2022)
45,626 (32,784 - 54,028) 2008 Modelled IHME, GBD 2019 (accessed 2022)
46,329 (32,915 - 55,060) 2007 Modelled IHME, GBD 2019 (accessed 2022)
46,747 (32,980 - 55,786) 2006 Modelled IHME, GBD 2019 (accessed 2022)
46,535 (32,346 - 56,042) 2005 Modelled IHME, GBD 2019 (accessed 2022)
45,957 (31,884 - 55,124) 2004 Modelled IHME, GBD 2019 (accessed 2022)
45,456 (31,380 - 54,408) 2003 Modelled IHME, GBD 2019 (accessed 2022)
44,975 (30,763 - 54,112) 2002 Modelled IHME, GBD 2019 (accessed 2022)
44,455 (30,134 - 53,972) 2001 Modelled IHME, GBD 2019 (accessed 2022)
43,837 (29,550 - 53,962) 2000 Modelled IHME, GBD 2019 (accessed 2022)
43,570 (29,631 - 53,337) 1999 Modelled IHME, GBD 2019 (accessed 2022)
43,866 (29,883 - 53,592) 1998 Modelled IHME, GBD 2019 (accessed 2022)
44,318 (30,226 - 54,123) 1997 Modelled IHME, GBD 2019 (accessed 2022)
44,554 (30,272 - 54,449) 1996 Modelled IHME, GBD 2019 (accessed 2022)
44,237 (29,858 - 54,277) 1995 Modelled IHME, GBD 2019 (accessed 2022)
43,673 (29,288 - 53,723) 1994 Modelled IHME, GBD 2019 (accessed 2022)
43,326 (28,570 - 53,330) 1993 Modelled IHME, GBD 2019 (accessed 2022)
43,111 (27,909 - 53,608) 1992 Modelled IHME, GBD 2019 (accessed 2022)
42,956 (27,290 - 53,641) 1991 Modelled IHME, GBD 2019 (accessed 2022)
42,790 (26,533 - 53,996) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.04 (6.63 - 12.10) 2019 Modelled IHME, GBD 2019 (accessed 2020)
12.19 (8.27 - 17.23) 1990 Modelled IHME, GBD 2019 (accessed 2022)
12 (8.29 - 16.61) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11.78 (8.02 - 16.09) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11.57 (8.10 - 15.48) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11.42 (7.93 - 15.34) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11.27 (7.90 - 14.96) 1995 Modelled IHME, GBD 2019 (accessed 2022)
11.11 (7.85 - 14.70) 1996 Modelled IHME, GBD 2019 (accessed 2022)
10.86 (7.66 - 14.36) 1997 Modelled IHME, GBD 2019 (accessed 2022)
10.59 (7.48 - 14.04) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10.02 (7.14 - 13.42) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10.27 (7.26 - 13.77) 1999 Modelled IHME, GBD 2019 (accessed 2022)
9.84 (7.02 - 13.14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
9.66 (6.88 - 12.70) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9.57 (6.95 - 12.75) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9.48 (6.88 - 12.53) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9.45 (6.76 - 12.57) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9.48 (6.80 - 12.57) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9.45 (6.97 - 12.58) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9.15 (6.81 - 12.18) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9.33 (6.86 - 12.41) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9.27 (6.81 - 12.28) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9.45 (7.01 - 12.49) 2011 Modelled IHME, GBD 2019 (accessed 2022)
9.5 (7 - 12.54) 2012 Modelled IHME, GBD 2019 (accessed 2022)
9.51 (7.04 - 12.39) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9.55 (7.04 - 12.57) 2014 Modelled IHME, GBD 2019 (accessed 2022)
9.51 (7.06 - 12.51) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9.41 (6.96 - 12.49) 2016 Modelled IHME, GBD 2019 (accessed 2022)
9.22 (6.77 - 12.35) 2017 Modelled IHME, GBD 2019 (accessed 2022)
9.05 (6.63 - 12.15) 2018 Modelled IHME, GBD 2019 (accessed 2022)
9.04 (6.63 - 12.13) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
51 2016 Modelled WHO
42 (28 - 59) 1990 Modelled IHME, GBD 2019 (accessed 2022)
43 (29 - 58) 1992 Modelled IHME, GBD 2019 (accessed 2022)
42 (29 - 58) 1991 Modelled IHME, GBD 2019 (accessed 2022)
43 (30 - 58) 1993 Modelled IHME, GBD 2019 (accessed 2022)
44 (30 - 59) 1994 Modelled IHME, GBD 2019 (accessed 2022)
45 (31 - 59) 1995 Modelled IHME, GBD 2019 (accessed 2022)
45 (32 - 60) 1996 Modelled IHME, GBD 2019 (accessed 2022)
45 (32 - 60) 1997 Modelled IHME, GBD 2019 (accessed 2022)
45 (32 - 60) 1998 Modelled IHME, GBD 2019 (accessed 2022)
45 (32 - 60) 1999 Modelled IHME, GBD 2019 (accessed 2022)
45 (32 - 60) 2000 Modelled IHME, GBD 2019 (accessed 2022)
45 (32 - 60) 2001 Modelled IHME, GBD 2019 (accessed 2022)
45 (32 - 60) 2002 Modelled IHME, GBD 2019 (accessed 2022)
47 (34 - 62) 2004 Modelled IHME, GBD 2019 (accessed 2022)
46 (33 - 61) 2003 Modelled IHME, GBD 2019 (accessed 2022)
49 (36 - 66) 2007 Modelled IHME, GBD 2019 (accessed 2022)
47 (34 - 63) 2005 Modelled IHME, GBD 2019 (accessed 2022)
49 (35 - 64) 2006 Modelled IHME, GBD 2019 (accessed 2022)
49 (36 - 65) 2008 Modelled IHME, GBD 2019 (accessed 2022)
51 (37 - 68) 2009 Modelled IHME, GBD 2019 (accessed 2022)
51 (38 - 68) 2010 Modelled IHME, GBD 2019 (accessed 2022)
53 (40 - 71) 2011 Modelled IHME, GBD 2019 (accessed 2022)
56 (41 - 73) 2013 Modelled IHME, GBD 2019 (accessed 2022)
55 (40 - 72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
58 (43 - 78) 2016 Modelled IHME, GBD 2019 (accessed 2022)
58 (43 - 76) 2015 Modelled IHME, GBD 2019 (accessed 2022)
57 (42 - 75) 2014 Modelled IHME, GBD 2019 (accessed 2022)
58 (43 - 78) 2017 Modelled IHME, GBD 2019 (accessed 2022)
58 (43 - 78) 2018 Modelled IHME, GBD 2019 (accessed 2022)
59 (43 - 80) 2019 Modelled IHME, GBD 2019 (accessed 2022)
59 (43 - 80) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
17 (13 - 21) 1990 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1991 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1992 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1993 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1994 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1995 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 21) 1996 Modelled IHME, GBD 2019 (accessed 2022)
17 (14 - 21) 1997 Modelled IHME, GBD 2019 (accessed 2022)
17 (14 - 21) 1998 Modelled IHME, GBD 2019 (accessed 2022)
17 (13 - 20) 2000 Modelled IHME, GBD 2019 (accessed 2022)
17 (14 - 21) 1999 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 20) 2001 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 19) 2002 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2003 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2004 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2007 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2005 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2006 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2008 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 18) 2009 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 18) 2010 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 19) 2011 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 19) 2012 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 19) 2013 Modelled IHME, GBD 2019 (accessed 2022)
17 (14 - 20) 2015 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 20) 2014 Modelled IHME, GBD 2019 (accessed 2022)
17 (14 - 20) 2016 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 20) 2017 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 20) 2018 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 20) 2019 Modelled IHME, GBD 2019 (accessed 2022)
54 (46 - 62) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
66 2019 Survey/reported WHO/UNICEF
67 2018 Survey/reported WHO/UNICEF
67 2017 Survey/reported WHO/UNICEF
67 2016 Survey/reported WHO/UNICEF
65 2015 Survey/reported WHO/UNICEF
62 2014 Survey/reported WHO/UNICEF
58 2013 Survey/reported WHO/UNICEF
59 2012 Survey/reported WHO/UNICEF
61 2011 Survey/reported WHO/UNICEF
62 2010 Survey/reported WHO/UNICEF
71 2009 Survey/reported WHO/UNICEF
80 2008 Survey/reported WHO/UNICEF
83 2007 Survey/reported WHO/UNICEF
81 2006 Survey/reported WHO/UNICEF
80 2005 Survey/reported WHO/UNICEF
78 2004 Survey/reported WHO/UNICEF
76 2003 Survey/reported WHO/UNICEF
73 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
70 2020 Survey/reported WHO/UNICEF
76 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
94 2019 Survey/reported WHO/UNICEF
94 2020 Survey/reported WHO/UNICEF
87 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.4 (0.32 - 0.48) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.48) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.32 - 0.48) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.48) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.48) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.33 - 0.49) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.33 - 0.49) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.33 - 0.49) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.32 - 0.49) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.32 - 0.48) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.31 - 0.47) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.30 - 0.45) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.36 (0.29 - 0.44) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.35 (0.28 - 0.42) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.34 (0.27 - 0.40) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.26 - 0.38) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.25 - 0.37) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.24 - 0.36) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.24 - 0.35) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.24 - 0.35) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.23 - 0.35) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.23 - 0.35) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.28 (0.23 - 0.34) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.29 - 0.46) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
1.34 (1.01 - 4.61) 2019 Modelled Dugan et al., 2021
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
938 (764 - 1,137) 1990 Modelled IHME, GBD 2019 (accessed 2022)
973 (795 - 1,179) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,010 (825 - 1,221) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,050 (858 - 1,265) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,092 (889 - 1,317) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,136 (925 - 1,366) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,197 (977 - 1,444) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,286 (1,047 - 1,550) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,389 (1,122 - 1,670) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,493 (1,209 - 1,797) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,584 (1,283 - 1,912) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,667 (1,342 - 2,015) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,754 (1,413 - 2,123) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,839 (1,477 - 2,225) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,914 (1,535 - 2,314) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,969 (1,582 - 2,384) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,010 (1,618 - 2,434) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,048 (1,649 - 2,474) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,084 (1,678 - 2,529) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,120 (1,707 - 2,580) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,159 (1,738 - 2,635) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,200 (1,775 - 2,671) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,239 (1,807 - 2,717) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,279 (1,842 - 2,757) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2,319 (1,877 - 2,805) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2,360 (1,910 - 2,860) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2,384 (1,925 - 2,885) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2,410 (1,951 - 2,920) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2,458 (1,991 - 2,978) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2,515 (2,026 - 3,056) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2,412 (1,906 - 2,987) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
2,100 (1,600 - 7,400) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
5.76 (4.01 - 7.98) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.38 (3.57 - 7.85) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5.35 (3.59 - 7.73) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5.3 (3.55 - 7.56) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5.25 (3.51 - 7.44) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5.22 (3.53 - 7.39) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5.2 (3.53 - 7.32) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5.23 (3.55 - 7.39) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5.34 (3.66 - 7.46) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5.48 (3.76 - 7.66) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5.59 (3.84 - 7.75) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5.65 (3.89 - 7.81) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5.66 (3.86 - 7.73) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5.65 (3.90 - 7.71) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.68 (3.96 - 7.78) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5.68 (4 - 7.71) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.7 (3.97 - 7.70) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.72 (4.07 - 7.81) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.7 (4.01 - 7.81) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.52 (3.89 - 7.61) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.63 (3.98 - 7.70) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.6 (3.96 - 7.61) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.8 (4.07 - 7.95) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.73 (4.03 - 7.76) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.77 (4.07 - 7.84) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.84 (4.07 - 8.03) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.85 (4.08 - 7.96) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.84 (4.06 - 8.04) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.81 (4.03 - 7.98) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.74 (3.97 - 7.96) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.76 (4.01 - 7.98) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4 2016 Modelled WHO
38 (26 - 52) 2019 Modelled IHME, GBD 2019 (accessed 2022)
38 (26 - 52) 2019 Modelled IHME, GBD 2019 (accessed 2020)
37 (26 - 51) 2018 Modelled IHME, GBD 2019 (accessed 2022)
37 (26 - 50) 2017 Modelled IHME, GBD 2019 (accessed 2022)
36 (25 - 50) 2016 Modelled IHME, GBD 2019 (accessed 2022)
36 (25 - 49) 2015 Modelled IHME, GBD 2019 (accessed 2022)
35 (24 - 48) 2014 Modelled IHME, GBD 2019 (accessed 2022)
34 (24 - 47) 2013 Modelled IHME, GBD 2019 (accessed 2022)
33 (23 - 45) 2012 Modelled IHME, GBD 2019 (accessed 2022)
32 (23 - 44) 2011 Modelled IHME, GBD 2019 (accessed 2022)
31 (22 - 42) 2010 Modelled IHME, GBD 2019 (accessed 2022)
31 (22 - 42) 2009 Modelled IHME, GBD 2019 (accessed 2022)
29 (21 - 41) 2008 Modelled IHME, GBD 2019 (accessed 2022)
30 (21 - 41) 2007 Modelled IHME, GBD 2019 (accessed 2022)
29 (21 - 40) 2006 Modelled IHME, GBD 2019 (accessed 2022)
29 (20 - 39) 2005 Modelled IHME, GBD 2019 (accessed 2022)
28 (20 - 38) 2004 Modelled IHME, GBD 2019 (accessed 2022)
27 (19 - 37) 2003 Modelled IHME, GBD 2019 (accessed 2022)
27 (18 - 36) 2002 Modelled IHME, GBD 2019 (accessed 2022)
26 (18 - 36) 2001 Modelled IHME, GBD 2019 (accessed 2022)
25 (17 - 35) 2000 Modelled IHME, GBD 2019 (accessed 2022)
25 (17 - 34) 1999 Modelled IHME, GBD 2019 (accessed 2022)
23 (16 - 33) 1998 Modelled IHME, GBD 2019 (accessed 2022)
22 (15 - 31) 1997 Modelled IHME, GBD 2019 (accessed 2022)
21 (14 - 30) 1996 Modelled IHME, GBD 2019 (accessed 2022)
21 (14 - 29) 1995 Modelled IHME, GBD 2019 (accessed 2022)
20 (14 - 28) 1994 Modelled IHME, GBD 2019 (accessed 2022)
20 (13 - 28) 1993 Modelled IHME, GBD 2019 (accessed 2022)
19 (13 - 27) 1992 Modelled IHME, GBD 2019 (accessed 2022)
19 (13 - 27) 1991 Modelled IHME, GBD 2019 (accessed 2022)
18 (12 - 27) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
5 (3 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1995 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1996 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2019 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 23) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
59
2019
(43 - 80)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
38
2019
(26 - 52)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
76 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners